Sanofi ( (SNY) ) has issued an announcement. Sanofi announced that the FDA has granted Breakthrough Therapy designation to tolebrutinib for treating non-relapsing secondary progressive multiple ...
Motherhood came knocking on Stephanie Handford’s door ten times. At just 21, she began welcoming foster children into her ...